Philips announced today that its WE-TRUST clinical trial enrolled its first patients in France and the U.S. The trial aims to evaluate whether a direct-to-angio suite (DTAS) workflow can improve outcomes for early time-window stroke patients. It compares this method to the conventional approach that uses a diagnostic MR/CT scan before transfer to the angio […]
Philips
Philips to repurchase up to 7.1M shares in effort to cover long-term incentives
Philips announced that it plans to repurchase up to 7.1 million shares. The Amsterdam-based medtech giant initiated this repurchase effort to cover certain obligations arising from long-term incentive plans. At the current share price, 7.1 million shares equals approximately $148.3 million (€132 million). Philips said in its announcement last month that it plans to execute […]
Philips, Biotronik partner to expand care for out-of-hospital cardiology labs
Philips today announced a new partnership with Biotronik. The companies teamed up to expand the range of cardiovascular devices available for Philips SymphonySuite customers. Biotronik develops products and services for treating cardiovascular and endovascular diseases. Philips designed its SymphonySuite for opening and expanding cardiovascular office-based labs OBLs and ambulatory surgery centers (ASCs). The Amsterdam-based medtech […]
Philips warns on potential breakage issue with certain Allura, Azurion systems
Philips issued an urgent field safety notice regarding some of its Allura and Azurion image-guided therapy systems. Affected systems only include Allura and Azurion products with the FlexMove system installed. The notice warns of an issue that may occur due to forces applied during the movement of the C-Arc for Allura and Azurion. Philips’ image-guided […]
Study backs Philips’ direct-to-angio stroke pathway
Philips announced today that a published analysis supports its stroke care pathway. Amsterdam-based Philips had results of the health economic analysis published in the Journal of NeuroInterventional Surgery (JNIS). Data demonstrated that the company’s approach to stroke care reduced costs by an average of $3,120 per patient. Philips’ retrospective analysis looked at data from the […]
New FDA clearance will boost Philips and Masimo partnership
Philips and Masimo today announced an FDA clearance that allows the incorporation of Masimo’s advanced monitoring tech into Philips’ existing high-acuity patient monitors. The FDA clearance allows the companies to use SedLine brain function monitoring, Regional Oximetry and CO2 measurements in Philips’ patient monitors, IntelliVue MX750 and MX850. This is the latest extension of Masimo […]
The top cardiac care innovation news at Heart Rhythm 2023
The future of cardiac care was on display at the Heart Rhythm Society’s 2023 annual meeting. Medical device companies showcased groundbreaking technologies at Heart Rhythm 2023, May 19-21 in New Orleans. The innovations presented during the event offer new avenues for diagnosis, treatment, and monitoring of cardiovascular conditions, providing hope for patients worldwide. Boston Scientific, […]
Philips study shows AI can help predict ventricular tachycardia
Philips (NYSE:PHG) presented data demonstrating how artificial intelligence (AI) can help predict life-threatening ventricular arrhythmias. Amsterdam-based Philips presented an abstract highlighting recent research at the annual Hearth Rhythm Society (HRS) congress in New Orleans. The study, “Near-Term Prediction of Life-Threatening Ventricular Arrhythmias using Artificial Intelligence-Enabled Single Lead Ambulatory ECG,” used an AI-based learning model. It […]
Philips launches AI-powered CT imaging system
Philips (NYSE:PHG) announced that it launched the Philips CT 3500, a new high-throughput CT system powered by artificial intelligence (AI). Amsterdam-based Philips designed the new CT system to target the needs of routine radiology and high-volume screening programs. It features a range of image-reconstruction and workflow-enhancing features to deliver consistency, speed and first-time-right image quality. […]
Philips: Study shows recalled CPAPs unlikely to cause appreciable harm
Philips (NYSE:PHG) today shared results from a test and research program for the ongoing recall within its Respironics subsidiary. The Amsterdam-based medtech giant says third-party test results determined that issues around its respiratory devices are unlikely to cause appreciable harm to health. These now-completed risk assessments fall in line with results shared by Philips in late […]
Philips to pay more than $62M to settle FCPA charges
The U.S. SEC announced that Philips will pay $62 million to resolve charges that Chinese subsidiaries violated the Foreign Corrupt Practices Act. The Dutch medtech giant consented to yesterday’s SEC order without admitting or denying the agency’s findings. It’ll pay $15 million in civil penalties and more than $47 million in disgorgement and prejudgment interest. […]